Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17640571 | 0.85 | CYP19A1 (0.46) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL21915384 | 0.85 | CYP19A1 (0.33) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL17640634 | 0.84 | CYP19A1 (0.45) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL17640574 | 0.83 | CYP19A1 (0.44) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL17640567 | 0.83 | CYP19A1 (0.44) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL21915467 | 0.82 | CYP19A1 (0.43) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL21915377 | 0.82 | CYP19A1 (0.43) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL21915530 | 0.81 | ALOX5 (0.37) | — | |
| SCHEMBL21915610 | 0.81 | CYP19A1 (0.38) | CYP19A1MAPTADORA3ADORA2AADORA2B | |
| SCHEMBL21915533 | 0.79 | MAPT (0.34) | CYP19A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | UDC IRELAND LIMITED (IE) | 2019-06-25 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| WO-2016046350-A1 | FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | NR2E3, CRY1, ALDH1A2 | CYP19A1 2245/4885MAPT 2708/4885ADORA3 1449/4885 |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | NR2E3, CRY1, ALDH1A2 | CYP19A1 2245/4885MAPT 2708/4885ADORA3 1449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.